Latest News

Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer
Read More
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets
Read More
Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design
Read More
Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development
Read More